These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3558730)

  • 1. Elevated urinary 19-Nor-deoxycorticosterone glucuronide in Cushing's syndrome.
    Ehlers ME; Griffing GT; Wilson TE; Melby JC
    J Clin Endocrinol Metab; 1987 May; 64(5):926-30. PubMed ID: 3558730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    J Clin Endocrinol Metab; 1983 Feb; 56(2):218-21. PubMed ID: 6337172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxycorticosterone and aldosterone excretion in Cushing's syndrome.
    Cassar J; Loizou S; Kelly WF; Mashiter K; Joplin GF
    Metabolism; 1980 Feb; 29(2):115-9. PubMed ID: 7354720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of urinary free 19-nor-deoxycorticosterone and its relation to systemic arterial blood pressure in normotensive and hypertensive subjects.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):99-103. PubMed ID: 6292258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary free 19-nor-deoxycorticosterone and deoxycorticosterone in human hypertension.
    Gomez-Sanchez CE; Holland OB; Upcavage R
    J Clin Endocrinol Metab; 1985 Feb; 60(2):234-8. PubMed ID: 3880766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unconjugated and conjugated urinary 19-nor-deoxycorticosterone glucosiduronate. Elevated levels in essential hypertension.
    Griffing GT; Wilson TE; Melby JC
    Hypertension; 1985; 7(3 Pt 2):I12-7. PubMed ID: 3873413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Special diagnosis in Cushing's syndrome].
    Tenschert W; Vetter H; Siebenschein R; Holland-Cunz B; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1981 Jan; 111(3):70-3. PubMed ID: 6944789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension and aldosterone overproduction without renin suppression in Cushing's syndrome from an adrenal adenoma.
    Guthrie GP; Kotchen TA
    Am J Med; 1979 Sep; 67(3):524-8. PubMed ID: 474601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diurnal 18-hydroxy-11-deoxycorticosterone pattern in human stable hypertension.
    Sparano F; Sciarra F; Sulon J; Giaquinto G; Mercuri MA; Odoardi A; Tosticroce C; Genard P; Conti C
    J Clin Endocrinol Metab; 1978 Oct; 47(4):829-33. PubMed ID: 400733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxycorticosterone excretion in normal, hypertensive and hypokalaemic subjects.
    Cope CL; Loizou S
    Clin Sci Mol Med; 1975 Feb; 48(2):97-105. PubMed ID: 1167821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian rhythms of urinary sodium, potassium and some agents influencing their excretion in young borderline hypertensives.
    Bultasová H; Veselková A; Brodan V; Pinsker P
    Endocrinol Exp; 1986 Dec; 20(4):359-69. PubMed ID: 3492363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary 19-nor-deoxycorticosterone and deoxycorticosterone in hypertensive disease of pregnancy.
    Shah DM; Gomez-Sanchez CE; Knuppel RA; Vaughn WK
    Am J Perinatol; 1987 Apr; 4(2):102-5. PubMed ID: 3566877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    Hypertension; 1983; 5(3):385-9. PubMed ID: 6341221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exaggerated blood pressure response to angiotensin II in patients with Cushing's syndrome due to adrenocortical adenoma.
    Yasuda G; Shionoiri H; Umemura S; Takasaki I; Ishii M
    Eur J Endocrinol; 1994 Dec; 131(6):582-8. PubMed ID: 7804440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and pathophysiology of Cushing's syndrome.
    Gabrilove JL; Krakoff LR
    Compr Ther; 1986 Jan; 12(1):17-21. PubMed ID: 3004801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cushing's disease: evaluation of mineralocorticoid-induced hypertension.
    Yasuda G; Shionoiri H; Hayashi S; Umemura S; Ikeda Y; Ishii M
    Intern Med; 1993 Oct; 32(10):784-8. PubMed ID: 8012073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and urinary 19-nor-deoxycorticosterone in 17 alpha-hydroxylase deficiency syndrome.
    Griffing GT; Wilson TE; Holbrook MM; Dale SL; Jackson TK; Ullrich I; Melby JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):1011-5. PubMed ID: 6332824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent hypercortisolism and hypermineralocorticoidism.
    Hogan MJ; Schambelan M; Biglieri EG
    Am J Med; 1977 May; 62(5):777-82. PubMed ID: 871129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transitory increment in urinary free 19-nor-deoxycorticosterone after diuretic-induced renin stimulation.
    Griffing GT; Wilson TE; Melby JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):931-5. PubMed ID: 6480812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.